Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2015 May 7;10(4):576–586. doi: 10.1007/s11481-015-9613-1

Table 2.

Current and Past Clinical Trials Evaluating Immunomodulatory Therapies

Hemorrhage type Agent Trial Phase Status References
Supratentorial Intracerebral Hemorrhage Prophylactic forced normothermia Systemic Normothermia in Intracerebral Hemorrhage (ICH) (SNICH) 0 Not Yet Recruiting (Rincon et al., 2014)
Intracerebral Hemorrhage Labetalol/Hydralazine/Enalapril The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II (ICH-ADAPT II) 2 Recruiting (Butcher et al., 2013)
Intracerebral Hemorrhage Pioglitazone Safety of Pioglitazone for Hematoma Resolution In Intracerebral Hemorrhage (SHRINC) 2 Ongoing (Gonzales et al., 2013)
Intracerebral Hemorrhage Minocycline A Pilot Study of Minocycline in Intracerebral Hemorrhage Patients (MACH) 2 Recruiting (Kohler et al., 2013)
Intracerebral Hemorrhage Rosuvastatin Effect of Rosuvastatin in Intracerebral Hemorrhage 2 Complete (Tapia-Perez et al., 2009)
Intracerebral hemorrhage Nicardipine IV Double and Triple Concentrated Nicardipine for Stroke and ICH 4 Unknown (Koga et al., 2014)